StockWatch
·

Genpharmasec Ltd Q4 FY25 Results

GENPHARMAQ4 FY25 Results
Filing
MetricValue ( Cr)vs Q3 FY25
Revenue14.0165.1%
Total Income14.9560.8%
Expenditure15.3792.1%
PBT-0.43133.0%
Net Profit-0.27134.7%
OPM-7.14%9.78pp
NPM-1.81%10.20pp
EPS0.010.0%
View full financials

Informational and educational content only. Not investment advice.